Abstract
Due to an oversight, one of the author’s name was published wrong in the article entitled “A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation” in “Anti-Cancer Agents in Medicinal Chemistry, 2015, Vol. 15, No. 4, pp. 517.”
The correct names of all authors are given below: Samar Said Fatahala*, Emad Ahmed Shalaby, Shaymaa Emam Kassab and Mossad Said Mohamed to Mossad Sayed Mohamed
Anti-Cancer Agents in Medicinal Chemistry
Title:CORRIGENDUM A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation
Volume: 18 Issue: 10
Author(s):
Affiliation:
Abstract: Due to an oversight, one of the author’s name was published wrong in the article entitled “A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation” in “Anti-Cancer Agents in Medicinal Chemistry, 2015, Vol. 15, No. 4, pp. 517.”
The correct names of all authors are given below: Samar Said Fatahala*, Emad Ahmed Shalaby, Shaymaa Emam Kassab and Mossad Said Mohamed to Mossad Sayed Mohamed
Export Options
About this article
Cite this article as:
, CORRIGENDUM A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation, Anti-Cancer Agents in Medicinal Chemistry 2018; 18 (10) . https://dx.doi.org/10.2174/187152061810181211124824
DOI https://dx.doi.org/10.2174/187152061810181211124824 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Renal & Ocular Targets for Therapy in Wegeners Granulomatosis
Inflammation & Allergy - Drug Targets (Discontinued) Stimuli-responsive Drug Delivery Nanosystems: From Bench to Clinic
Current Nanomedicine The Function and Regulation of BMP6 in Various Kinds of Stem Cells
Current Pharmaceutical Design Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Noninvasive Imaging of Therapeutic Effect
Current Drug Discovery Technologies Recent Studies on Inhibition of Enzymes Leading to Prostate and Breast Cancers
Current Enzyme Inhibition Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology B-Lymphocytes Govern the Pathogenesis of Sjogren's Syndrome
Current Pharmaceutical Biotechnology System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening
Current Medicinal Chemistry A Computational Study of Three Frequent Mutations of EGFR and their Effects on Protein Dimer Formation and Non-Small Cell Lung Cancer Drug Resistance
Current Bioinformatics Mechanisms to Inhibit Matrix Metalloproteinase Activity: Where are we in the Development of Clinically Relevant Inhibitors?
Recent Patents on Anti-Cancer Drug Discovery Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly
Current Pharmaceutical Design Gene Delivery for Cancer Therapy
Current Drug Delivery Hybrid Polymeric-Magnetic Nanoparticles in Cancer Treatments
Current Pharmaceutical Design An Update on Developments in Female Hormonal Contraception
Current Women`s Health Reviews Chemotherapy in Addition to Preoperative Radiotherapy in Locally Advanced Rectal Cancer – A Systematic Overview
Reviews on Recent Clinical Trials Novel Non-Competitive Antagonists of Kainate GluK1/GluK2 Receptors
Letters in Drug Design & Discovery Overview
Anti-Cancer Agents in Medicinal Chemistry Genetic Polymorphisms in UDP-Glucuronosyltransferase 1A6 Are Not Associated with NSAIDs-Related Peptic Ulcer Haemorrhage
Drug Metabolism Letters Nanoemulsion for Migraine Prophylaxis Nasal Drug Delivery: Preparation, Characterization and in vitro Evaluation
Pharmaceutical Nanotechnology Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy
Current Cancer Drug Targets